TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 1819317

Group type: EXPERIMENTAL
Intervention: Epoprostenol sodium (prostacyclin)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Heparin sodium
Number of subjects: 30
Study: 6215056

Group type: EXPERIMENTAL
Intervention: 13-cis-retinoic acid
Number of subjects: 48
Study: 31269004

Group type: EXPERIMENTAL
Intervention: High-Intensity Training (HIT)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Moderate-Intensity Training (MIT)
Number of subjects: 38
Study: 28991146

Group type: EXPERIMENTAL
Intervention: Mediational Intervention for Sensitizing Caregivers (MISC) training emphasizing cognitive stimulation
Number of subjects: 221

Group type: COMPARATOR
Intervention: UCOBAC program that delivered health and nutrition training
Number of subjects: 221
Study: 25896457

Group type: EXPERIMENTAL
Intervention: KAMRA small-aperture inlay
Number of subjects: 507

Group type: COMPARATOR
Intervention: Crystalens Advanced Optics (AO)
Number of subjects: 507

Group type: COMPARATOR
Intervention: AcrySof IQ ReSTOR +3.0 D
Number of subjects: 507

Group type: COMPARATOR
Intervention: Tecnis +4D Multifocal (MF)
Number of subjects: 507
Study: 23710812

Group type: EXPERIMENTAL
Intervention: RT-CGM group
Number of subjects: 123

Group type: COMPARATOR
Intervention: GM group (control)
Number of subjects: 123
Study: 21248199

Group type: EXPERIMENTAL
Intervention: High protein and high PRAL diet (HPHP; total protein: 118 g/d; PRAL: 33 mEq/d)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Low protein and low PRAL diet (LPLP; total protein: 61 g/d; PRAL: ‐48 mEq/d)
Number of subjects: 16
Study: 19549294

Group type: COMPARATOR
Intervention: Physical Training (PT)
Number of subjects: 254

Group type: COMPARATOR
Intervention: Physical Training with Cognitive Behavioral Component and Workplace Specific Exercises (PTCBWE)
Number of subjects: 254

Group type: EXPERIMENTAL
Intervention: Usual Care (corresponding to PT)
Number of subjects: 254

Group type: EXPERIMENTAL
Intervention: Usual Care (corresponding to PTCBWE)
Number of subjects: 254
Study: 18177195

Group type: EXPERIMENTAL
Intervention: Cleft lip participants
Number of subjects: 84

Group type: COMPARATOR
Intervention: Noncleft participants
Number of subjects: 84
Study: 15049467

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 11499461

Group type: EXPERIMENTAL
Intervention: Positive Presentation Management (PPM) and Negative Presentation Management (NPM) validity scales
Number of subjects: 369

Group type: EXPERIMENTAL
Intervention: NPM - PPM index
Number of subjects: 369
Study: 9745413

Group type: EXPERIMENTAL
Intervention: 0.3 mg/kg.week recombinant human GH
Number of subjects: 62
Study: 8751029

Group type: EXPERIMENTAL
Intervention: Spirapril 1.5 mg
Number of subjects: 248

Group type: EXPERIMENTAL
Intervention: Spirapril 3 mg
Number of subjects: 248

Group type: EXPERIMENTAL
Intervention: Spirapril 6 mg
Number of subjects: 248

Group type: EXPERIMENTAL
Intervention: Enalapril 5/10 mg
Number of subjects: 248

Group type: COMPARATOR
Intervention: Pooled Spirapril groups
Number of subjects: 248

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 248
Study: 2533374

Group type: EXPERIMENTAL
Intervention: Cortison and local anaesthetic injected intra‐articularly into two facet joints (28 patients)
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: Cortison and local anaesthetic injected pericapsularly around two facet joints (39 patients)
Number of subjects: 109

Group type: COMPARATOR
Intervention: Physiologic sodium hydrochloride injected intra‐articularly into two facet joints (42 patients)
Number of subjects: 109
Study: 83697

Group type: EXPERIMENTAL
Intervention: Audio-visual teaching aids
Number of subjects: 0

Group type: COMPARATOR
Intervention: Printed teaching aids
Number of subjects: 0
Study: 29948216

Group type: EXPERIMENTAL
Intervention: High-polyphenols cocoa powder
Number of subjects: 20

Group type: COMPARATOR
Intervention: Maltodextrins (control)
Number of subjects: 20
Study: 27925426

Group type: EXPERIMENTAL
Intervention: Multiple micronutrient powder (MNP) for 2-3 months
Number of subjects: 794

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 794
Study: 26464495

Group type: EXPERIMENTAL
Intervention: Platelet-rich plasma injection
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Saline injection
Number of subjects: 54

Group type: COMPARATOR
Intervention: N/A (baseline echo types I + II)
Number of subjects: 54
Study: 25095774

Group type: EXPERIMENTAL
Intervention: Alcohol intoxication at 0.06% and 0.10% blood alcohol concentration
Number of subjects: 25
Study: 23138238

Group type: EXPERIMENTAL
Intervention: Periacetabular osteotomy with femoral head-neck osteochondroplasty
Number of subjects: 88

Group type: COMPARATOR
Intervention: Isolated periacetabular osteotomy
Number of subjects: 88
Study: 19665770

Group type: EXPERIMENTAL
Intervention: Milk oral immunotherapy (MOIT)
Number of subjects: 0
Study: 17886454

Group type: EXPERIMENTAL
Intervention: Resin coating consisting of a self-etching primer bonding system (Clearfil SE Bond) and a low-viscosity microfilled resin (Protect Liner F) applied to 10 cavities.
Number of subjects: 20

Group type: COMPARATOR
Intervention: No resin coating applied (non-coating group) in the other 10 cavities.
Number of subjects: 20
Study: 15064544

Group type: EXPERIMENTAL
Intervention: Radiofrequency coagulation
Number of subjects: 80

Group type: COMPARATOR
Intervention: Rubber band ligation
Number of subjects: 80
Study: 12053028

Group type: EXPERIMENTAL
Intervention: 50 mg of oral sildenafil citrate combined with self‐manual and visual sexual stimulation
Number of subjects: 41

Group type: COMPARATOR
Intervention: Combined intracavernosal injection of 60 mg of papaverine and sexual stimulation (CIS)
Number of subjects: 41
Study: 10444027

Group type: EXPERIMENTAL
Intervention: SC602 vaccine
Number of subjects: 36
Study: 7916183

Group type: EXPERIMENTAL
Intervention: RP 56976 (docetaxel) at 60 mg/m2
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: RP 56976 (docetaxel) at 70-90 mg/m2
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: RP 56976 (docetaxel)
Number of subjects: 27
Study: 2666293

Group type: EXPERIMENTAL
Intervention: Famotidine (1 40 mg tablet at night)
Number of subjects: 143

Group type: COMPARATOR
Intervention: Ranitidine (2 150 mg tablets at night)
Number of subjects: 143
Study: 1234507

Group type: EXPERIMENTAL
Intervention: Intramuscular salbutamol (8 mug/kg)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Intramuscular salbutamol (4 mug/kg)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Intramuscular salbutamol (12 mug/kg)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study: 30712734

Group type: EXPERIMENTAL
Intervention: 6-week expressive writing intervention (Transform Your Life: Write to Heal)
Number of subjects: 39
Study: 28343658

Group type: EXPERIMENTAL
Intervention: TEACH text message intervention (45 unique text messages over 3 months)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Standard of care treatment (control group)
Number of subjects: 61
Study: 24986051

Group type: EXPERIMENTAL
Intervention: TheraBite jaw exercise device
Number of subjects: 50

Group type: COMPARATOR
Intervention: Engström jaw exercise device
Number of subjects: 50
Study: 23800615

Group type: EXPERIMENTAL
Intervention: Participants not told the speaker had schizophrenia
Number of subjects: 0

Group type: COMPARATOR
Intervention: Participants told the speaker had schizophrenia
Number of subjects: 0
Study: 21659887

Group type: EXPERIMENTAL
Intervention: Pomegranate juice
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study: 17869079

Group type: EXPERIMENTAL
Intervention: 1.2g IV Magnesium sulphate
Number of subjects: 129

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 129
Study: 17054107

Group type: EXPERIMENTAL
Intervention: Lanreotide Autogel (Lan ATG) 120 mg every 6 weeks
Number of subjects: 60

Group type: COMPARATOR
Intervention: Lanreotide microparticles (Lan MP) 60 mg every 3 weeks
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 60
Study: 15333422

Group type: EXPERIMENTAL
Intervention: Enteral feeding supplemented with antioxidants (vitamins C and E)
Number of subjects: 216

Group type: COMPARATOR
Intervention: Control group (isocaloric formula)
Number of subjects: 216
Study: 11550163

Group type: EXPERIMENTAL
Intervention: Preoperative radiotherapy (RT+) with 25 grays in 1 week
Number of subjects: 557

Group type: COMPARATOR
Intervention: Surgery alone (RT-)
Number of subjects: 557

Group type: EXPERIMENTAL
Intervention: Preoperative radiotherapy (RT+)
Number of subjects: 557

Group type: EXPERIMENTAL
Intervention: All included patients with preoperative radiotherapy (RT+)
Number of subjects: 557
Study: 9024246

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Cyproheptadine (8 mg)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Valproic acid (1 g)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Cyproheptadine plus Valproic acid
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Bromocriptine (2.5 mg)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Combination of bromocriptine, cyproheptadine, and valproic acid
Number of subjects: 6
Study: 8031230

Group type: EXPERIMENTAL
Intervention: Incentive program (vouchers for retail items contingent on submitting cocaine-free urine specimens)
Number of subjects: 40

Group type: COMPARATOR
Intervention: No incentives (no vouchers)
Number of subjects: 40
Study: 3056447

Group type: EXPERIMENTAL
Intervention: Captopril (25 mg twice daily)
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Capozide (captopril, 25 mg with 15 mg hydrochlorothiazide)
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Captopril (50 mg twice daily)
Number of subjects: 99

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 99
Study: 31190588

Group type: EXPERIMENTAL
Intervention: High mental effort during reading and speaking tasks
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Low mental effort during reading and speaking tasks
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: High mental effort followed by a period of relaxation
Number of subjects: 104
Study: 31244318

Group type: EXPERIMENTAL
Intervention: Health beliefs related to perceived severity, benefits, motivator factors, and cues to action.
Number of subjects: 520

Group type: EXPERIMENTAL
Intervention: Health beliefs related to perceived severity, susceptibility, motivator factors, and self-efficacy.
Number of subjects: 520

Group type: EXPERIMENTAL
Intervention: Action stage of mammography adoption.
Number of subjects: 520

Group type: EXPERIMENTAL
Intervention: Pre-contemplation, relapse, and contemplation stages of mammography adoption.
Number of subjects: 520
Study: 27566475

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided injections
Number of subjects: 41

Group type: COMPARATOR
Intervention: Blind injections
Number of subjects: 41
Study: 25412712

Group type: EXPERIMENTAL
Intervention: Brief Intervention Group (BIG)
Number of subjects: 476

Group type: COMPARATOR
Intervention: Contact-Control Group (CCG)
Number of subjects: 476

Group type: COMPARATOR
Intervention: No-Contact-Control Group (NCG)
Number of subjects: 476
Study: 23681293

Group type: EXPERIMENTAL
Intervention: Stop signal in selective response inhibition tasks
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Improved control of stop signal influences
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lateralized readiness potential measurement
Number of subjects: 0
Study: 22655499

Group type: EXPERIMENTAL
Intervention: Stentless aortic valve (SAV)
Number of subjects: 225

Group type: COMPARATOR
Intervention: Conventional stented bioprosthesis (CSB)
Number of subjects: 225
Study: 19862000

Group type: EXPERIMENTAL
Intervention: Chemotherapy (vinorelbine and gemcitabine followed by docetaxel, or paclitaxel and carboplatin)
Number of subjects: 387
Study: 16856621

Group type: EXPERIMENTAL
Intervention: pegylated interferon (peg‐INF)‐alpha2a 180 microg/week plus ribavirin 800 mg/d for 12 weeks, followed by extended treatment for 72 weeks (extension arm)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Standard treatment (12 weeks)
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: pegylated interferon (peg‐INF)‐alpha2a 180 microg/week plus ribavirin 800 mg/d for 12 weeks, followed by additional 12 or 36 weeks depending on genotype for those achieving EVR
Number of subjects: 110
Study: 12538787

Group type: EXPERIMENTAL
Intervention: Parenteral nutrition and 20 mL breast milk/kg/d (BM)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Parenteral nutrition and 20 mL formula/kg/d (F)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Solely parenteral nutrition (C)
Number of subjects: 38
Study: 11057498

Group type: EXPERIMENTAL
Intervention: New hub device
Number of subjects: 130

Group type: COMPARATOR
Intervention: Control group (standard good clinical procedures)
Number of subjects: 130
Study: 9055140

Group type: EXPERIMENTAL
Intervention: Combination of H1 blocker dimetindene maleate (0.1 mg/kg) and H2 blocker cimetidine (5 mg/kg)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 8416660

Group type: EXPERIMENTAL
Intervention: Dietary intervention (2.1 MJ-deficit/d for 16 weeks) with formal exercise instruction
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Dietary intervention (2.1 MJ-deficit/d for 16 weeks) with informal exercise instruction
Number of subjects: 19
Study: 3314726

Group type: EXPERIMENTAL
Intervention: Human pituitary growth hormone
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 29076581

Group type: EXPERIMENTAL
Intervention: Coughing
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Blowing into a spirometer
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Squeezing a stress ball
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 120
Study: 28345174

Group type: EXPERIMENTAL
Intervention: Group A (Iodixanol 320 and 80 Kvp tube voltage)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Group B (Iodixanol 320 and 100 Kvp tube voltage)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Group C (Iomeprol 400 and 80 Kvp tube voltage)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Group D (Iomeprol 400 and 100 Kvp tube voltage)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Groups with 80 kV
Number of subjects: 200
Study: 26082504

Group type: EXPERIMENTAL
Intervention: Efavirenz with daily rifapentine and isoniazid
Number of subjects: 87
Study: 24229539

Group type: EXPERIMENTAL
Intervention: Child-parent psychotherapy (CPP)
Number of subjects: 137

Group type: EXPERIMENTAL
Intervention: Psychoeducational parenting intervention (PPI)
Number of subjects: 137

Group type: COMPARATOR
Intervention: Community standard (CS)
Number of subjects: 137

Group type: COMPARATOR
Intervention: Nonmaltreated comparison (NC)
Number of subjects: 137
Study: 20085176

Group type: EXPERIMENTAL
Intervention: Black cohosh-containing preparations
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study: 18295937

Group type: EXPERIMENTAL
Intervention: Beer (633 ml)
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Red wine (264 ml)
Number of subjects: 5

Group type: COMPARATOR
Intervention: White wine (264 ml)
Number of subjects: 5

Group type: COMPARATOR
Intervention: Whisky (79 ml)
Number of subjects: 5

Group type: COMPARATOR
Intervention: Water (250 ml)
Number of subjects: 5
Study: 16923409

Group type: EXPERIMENTAL
Intervention: Intracoronary infusion of autologous mononuclear bone marrow cells
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Intracoronary infusion of peripheral mononuclear blood cells
Number of subjects: 200

Group type: COMPARATOR
Intervention: Standard therapy
Number of subjects: 200
Study: 14638501

Group type: COMPARATOR
Intervention: Intranasal ruprintrivir (8 mg) prophylaxis 5x/day for 5 days
Number of subjects: 202

Group type: COMPARATOR
Intervention: Intranasal ruprintrivir (8 mg) prophylaxis 2x/day for 5 days
Number of subjects: 202

Group type: COMPARATOR
Intervention: Intranasal ruprintrivir (8 mg) treatment 5x/day for 4 days
Number of subjects: 202

Group type: COMPARATOR
Intervention: Intranasal ruprintrivir treatment
Number of subjects: 202
Study: 10814771

Group type: EXPERIMENTAL
Intervention: Haloperidol 5 mg/day
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Haloperidol 25 mg/day
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Haloperidol (both doses)
Number of subjects: 31
Study: 8891147

Group type: EXPERIMENTAL
Intervention: Clarithromycin (CLA; 500 mg given twice daily for nine doses)
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Clarithromycin (CLA)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Azithromycin (AZ; 500 mg for the first dose and then 250 mg once daily for four doses)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Azithromycin (AZ)
Number of subjects: 41
Study: 1642616

Group type: EXPERIMENTAL
Intervention: high dose intravenous immunoglobulin
Number of subjects: 33

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 33
Study: 6678826

Group type: EXPERIMENTAL
Intervention: Midazolam 15mg
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Midazolam 15mg + Alcohol 0.5g/kg
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8

Group type: COMPARATOR
Intervention: Alcohol 0.5g/kg
Number of subjects: 8
Study: 31888234

Group type: EXPERIMENTAL
Intervention: Amaranth oil (20 mL)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Rapeseed oil (20 mL)
Number of subjects: 0
Study: 29871673

Group type: EXPERIMENTAL
Intervention: Test and Treat (TnT) intervention in intervention colleges (n=3)
Number of subjects: 480

Group type: COMPARATOR
Intervention: Control group (no TnT) in control colleges (n=3)
Number of subjects: 480
Study: 26362233

Group type: EXPERIMENTAL
Intervention: Spinal manipulative therapy
Number of subjects: 62

Group type: COMPARATOR
Intervention: Functional technique
Number of subjects: 62
Study: 23506245

Group type: EXPERIMENTAL
Intervention: Continuous intravenous insulin (target blood glucose 80‐130 mg/dL, 4·44‐7·21 mmol/L) for up to 72 h
Number of subjects: 1400

Group type: COMPARATOR
Intervention: Standard sliding scale subcutaneous insulin (blood glucose range 80‐179 mg/dL, 4·44‐9·93 mmol/L) for up to 72 h
Number of subjects: 1400

Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 1400
Study: 22453725

Group type: EXPERIMENTAL
Intervention: Room air
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Transport above 5000 ft
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Mechanical ventilation above 5000 ft
Number of subjects: 17
Study: 20808101

Group type: EXPERIMENTAL
Intervention: Memory and organizational aid
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard consent
Number of subjects: 0
Study: 18059592

Group type: EXPERIMENTAL
Intervention: Brief PA counselling (2-4 min) from a health care provider
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Brief PA counselling + intensive PA counselling from a PA counsellor (3 months)
Number of subjects: 120
Study: 15746735

Group type: EXPERIMENTAL
Intervention: Calcium channel blocker therapy with oral diltiazem 120 mg/daily
Number of subjects: 100

Group type: COMPARATOR
Intervention: No calcium channel blocker therapy
Number of subjects: 100
Study: 11985633

Group type: EXPERIMENTAL
Intervention: Ropinirole monotherapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Levodopa
Number of subjects: 0

Group type: COMPARATOR
Intervention: Bromocriptine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 10594415

Group type: EXPERIMENTAL
Intervention: Bupivacaine 0.5%
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: 50:50 mixture of bupivacaine 0.5%/lignocaine 2% with 1:200,000 adrenaline
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Lignocaine 2% with 1:200,000 adrenaline
Number of subjects: 90
Study: 8675719

Group type: EXPERIMENTAL
Intervention: Standard EMD protocol with eye movements
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Moving audio stimulus in place of the eye movements
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Protocol with eyes resting on the hands
Number of subjects: 40

Group type: COMPARATOR
Intervention: No-treatment control condition
Number of subjects: 40
Study: 1369705

Group type: EXPERIMENTAL
Intervention: Nicardipine 60-90 mg/day (n = 9)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo (n = 11)
Number of subjects: 20
Study: 7350052

Group type: EXPERIMENTAL
Intervention: Metoclopramide
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Bethanechol
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (healthy controls, asymptomatic diabetic patients, asymptomatic postsurgical patients)
Number of subjects: 0
Study: 31928097

Group type: COMPARATOR
Intervention: Cemented TKA
Number of subjects: 115177

Group type: EXPERIMENTAL
Intervention: Uncemented TKA
Number of subjects: 115177

Group type: EXPERIMENTAL
Intervention: Hybrid TKA
Number of subjects: 115177

Group type: EXPERIMENTAL
Intervention: Inverse Hybrid TKA
Number of subjects: 115177
Study: 31131904

Group type: EXPERIMENTAL
Intervention: Reciproc Blue
Number of subjects: 30

Group type: COMPARATOR
Intervention: M-Wire Reciproc
Number of subjects: 30
Study: 28658109

Group type: EXPERIMENTAL
Intervention: LMA
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Cobra PLA
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Air‐Q
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: SALT
Number of subjects: 79
Study: 26743243

Group type: EXPERIMENTAL
Intervention: Autologous peripheral blood stem cell (APBSC) transplantation
Number of subjects: 68

Group type: COMPARATOR
Intervention: Conventional treatment (Control group)
Number of subjects: 68
Study: 23294168

Group type: EXPERIMENTAL
Intervention: 0.5% carmellose sodium with added lipid (Drop C‐L)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: 1.0% glycerine with added lipid (Drop G‐L)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: 0.5% carmellose sodium (Drop C)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Control group (normal subjects)
Number of subjects: 37
Study: 19428142

Group type: EXPERIMENTAL
Intervention: Modality-specific attention training program
Number of subjects: 66

Group type: COMPARATOR
Intervention: Educational lecture control program
Number of subjects: 66
Study: 19815592

Group type: EXPERIMENTAL
Intervention: Transcendental Meditation program plus standard care
Number of subjects: 130

Group type: COMPARATOR
Intervention: Standard care alone
Number of subjects: 130
Study: 17046973

Group type: EXPERIMENTAL
Intervention: Familiarity heuristic (index test)
Number of subjects: 1378

Group type: COMPARATOR
Intervention: Not applicable (control group not specified)
Number of subjects: 1378